NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
ID: 347883Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/347883

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-020.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled the NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program, aimed at enhancing the rigor and transparency of neuroscience research within academic institutions. This initiative seeks to establish innovative programs at various intra-institutional levels to promote high-quality research practices, addressing issues such as bias and methodological rigor in scientific studies. The NIH plans to allocate approximately $3.5 million annually for at least five awards, with individual budgets typically ranging from $150,000 to $800,000 per year and a maximum project duration of three years. Interested applicants, including higher education institutions and various nonprofit and government entities, must submit their applications by October 17, 2025, and can find further details and submission instructions at the provided NIH link or by contacting grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-NS-24-020-Full-Announcement.html
    RFA-NS-24-020.html
    The National Institutes of Health (NIH) is offering a funding opportunity titled NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) to enhance the rigor and transparency of neuroscience research within academic institutions. This program is focused on creating innovative programs at various intra-institutional levels to promote high-quality research practices that address issues such as bias in the scientific process and lack of rigorous methodologies. The NIH intends to allocate approximately $3.5 million annually for at least five awards, with budgets typically ranging from $150,000 to $800,000 per year and a maximum project duration of three years. Eligible applicants include higher education institutions and various nonprofit and government entities involved in neuroscience research relevant to the NINDS mission. The application deadlines begin on September 17, 2023, with extensive instructions on submission details and program requirements. This funding initiative aims to foster a culture of rigorous research and accountability, encouraging institutions to adopt and disseminate best practices within the broader scientific community, ultimately improving the integrity and value of scientific findings in neuroscience.
    Similar Opportunities
    NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke (NINDS), has announced a funding opportunity titled "NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)" aimed at enhancing research education in biomedical, behavioral, and clinical research. This initiative seeks applications for innovative educational activities that provide hands-on research experiences and skills development, particularly in the field of neuroscience, with a maximum funding of $250,000 per year for up to five years. The program emphasizes diversity recruitment and significant institutional commitment, requiring applicants to include a comprehensive evaluation plan and adhere to strict guidelines. Interested parties can find more information and apply by July 14, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)," aimed at enhancing research experiences for resident clinicians in training. This initiative seeks to recruit, retain, and foster the independence of clinician-investigators by providing them with essential research opportunities early in their careers, thereby supporting basic, clinical, and translational research efforts. Although applications are not currently being solicited, potential applicants are encouraged to prepare meaningful collaborations and projects in anticipation of the forthcoming Notice of Funding Opportunity (NOFO). Interested parties can reach out to Dr. David Schopfer at david.schopfer@nih.gov or by phone at 301-402-3833 for further information, with the estimated synopsis posting date on July 11, 2025, and a projected award date of May 1, 2026.
    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)." This initiative aims to support the characterization and efficacy studies of neurotherapeutic agents intended for treating neurological disorders, with a focus on conducting pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate the biological activity of proposed therapeutic agents. The program emphasizes the importance of rigorous experimental design, collaboration, and the inclusion of diverse perspectives in research teams, aligning with NIH's mission to translate research discoveries into effective therapies. Interested applicants can apply for funding up to $499,000 per year for a total project duration not exceeding three years, with the application deadline set for October 20, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-225.html.
    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Innovation Grants to Nurture Initial Translational Efforts (IGNITE) funding opportunity, aimed at supporting pharmacodynamic, pharmacokinetic, and in vivo efficacy studies of therapeutic agents for neurological and neuromuscular disorders. This grant follows the R61/R33 phased award mechanism, where the R61 phase focuses on preparation and characterization, while the R33 phase emphasizes efficacy studies, with a critical transition contingent upon meeting specific milestones. The program encourages collaboration among various organizations, including nonprofit entities and academic institutions, to accelerate the development of promising therapies, with awards capped at $750,000 over a maximum project duration of three years. Interested applicants can find more information and application instructions at the NIH grants website, and the deadline for submissions is October 20, 2027.
    NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce the NIH Director’s Transformative Research Awards, a federal grant opportunity aimed at supporting innovative and unconventional research projects. This program encourages individual scientists or collaborative teams to propose groundbreaking research that has the potential to redefine scientific paradigms or develop transformative technologies, without the need for preliminary data or detailed experimental plans. With an estimated total funding of $8 million and the expectation of awarding seven grants, interested applicants should prepare their proposals in advance, as applications will be solicited starting June 20, 2025, with a closing date of September 3, 2025. For further inquiries, potential applicants can contact Dr. Patricia Labosky at TransformativeAwards@mail.nih.gov or by phone at 301-594-4863.
    B-INSPIRE: Research on Behavioral Interventions that Promote Careers in the Biomedical Research Enterprise (R01 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled B-INSPIRE, aimed at researching behavioral interventions that promote careers in the biomedical research enterprise. This initiative encourages applications that propose innovative studies designed to enhance interest, motivation, persistence, and preparedness among individuals pursuing biomedical research careers, with a strong emphasis on increasing workforce diversity. Eligible applicants include a wide range of organizations, particularly those serving underrepresented groups, and proposals must include a Plan for Enhancing Diverse Perspectives (PEDP) to address inclusivity strategies. The funding supports projects for up to five years, with applications due by October 14, 2026. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-230.html.
    Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Translational Research Training Program (T32), a federal grant aimed at equipping advanced predoctoral students, postdoctoral fellows, and fellowship-stage clinicians with the skills necessary to advance basic research toward clinical application, particularly in the field of neuroscience. This program emphasizes a cohesive educational approach that integrates training in experimental design, statistical analysis, and effective communication, while fostering interdisciplinary collaboration among scientists and clinicians and providing exposure to industry and regulatory processes. The grant will cover stipends, tuition, and training-related expenses for a duration of two years, with a focus on enhancing diversity in biomedical research. Interested applicants can find more information and apply by May 25, 2026, and should direct inquiries to grantsinfo@nih.gov.
    Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed) to support innovative and exploratory research projects in neuroscience. This grant program is designed for early-stage projects that align with the missions of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH), focusing on studies that assess the feasibility of novel investigations with the potential for significant breakthroughs in neuroscience. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and foreign entities, with funding available up to $275,000 over two years. The application period opens on January 16, 2025, with anticipated awards by July 2025; interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of General Medical Sciences (NIGMS), is offering funding under the Innovative Programs to Enhance Research Training (IPERT) initiative (R25) to support educational activities aimed at enhancing the biomedical research workforce. The program seeks to develop innovative courses, curriculum methods, and mentoring activities for participants at various career stages, from undergraduates to professionals, with a strong emphasis on inclusivity through a required Plan for Enhancing Diverse Perspectives (PEDP). This funding opportunity is crucial for broadening access to research training and addressing the evolving needs of the biomedical sector, with a maximum budget of $500,000 per year for a project period of up to five years. Interested applicants can find more information and guidelines at the NIH grants website and should direct inquiries to grantsinfo@nih.gov, with applications due by October 14, 2026.
    Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Stimulating Access to Research in Residency Transition Scholar (StARRTS)" aimed at supporting career development for new investigators in biomedical, behavioral, and clinical research. This program is designed for candidates who have completed a R38 program, facilitating their transition to research independence and addressing the nation's research needs. While applications are not currently being solicited, potential applicants are encouraged to prepare meaningful collaborations and projects in anticipation of the opportunity, which is expected to open for applications in August 2025. Interested parties can reach out to Dr. David Schopfer at david.schopfer@nih.gov or by phone at 301-402-3833 for further information.